|
"Oncorequisite" Genes in MYC-mediated Transformation
|
4R00CA134743-03
|
$233,147
|
$46,629
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
'Exvading' Invasive Pediatric Brain Tumors
|
5R01CA153229-03
|
$245,762
|
$245,762
|
Bellamkonda, Ravi
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
A Novel Modulator of Notch in Acute Lymphoblastic Leukemia
|
5R21CA161436-02
|
$176,175
|
$176,175
|
Liang, Chengyu
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Novel sequencing-based approach to discovering rare genetic factors for ALL.
|
5K08CA140720-03
|
$149,387
|
$149,387
|
Druley, Todd
|
WASHINGTON UNIVERSITY
|
|
A Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL
|
5R21CA161688-02
|
$321,931
|
$321,931
|
Burke, Michael
|
UNIVERSITY OF MINNESOTA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
$1,158,759
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Acidic Phospholipid-Selective Treatment for Neuroblastoma
|
5R01CA158372-02
|
$330,349
|
$330,349
|
QI, XIAOYANG
|
UNIVERSITY OF CINCINNATI
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIASC010378
|
$441,016
|
$220,508
|
Aplan, Peter
|
CCR (NCI)
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIABC010984
|
$1,556,987
|
$46,710
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
5R01CA132899-04
|
$335,446
|
$335,446
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
|
5R01CA139032-04
|
$322,040
|
$161,020
|
Muschen, Markus
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
ALL therapy and developing brains: MRI measures, genetic factors and cognition
|
5R01CA090246-07
|
$380,224
|
$380,224
|
REDDICK, WILBURN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-02
|
$170,100
|
$85,050
|
Bleakley, Marie
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
|
1R01CA170250-01
|
$594,337
|
$594,337
|
NESS, SCOTT
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Amplifying Radiation Potency Against Leukemic Stem Cells
|
1R21CA164098-01
|
$211,410
|
$211,410
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
An Investigation of Radial Glia as the Source of Ependymoma Stem Cells
|
2R01CA129541-06
|
$322,525
|
$161,263
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Anatomic Pathology Residency Program
|
ZIEBC011384
|
$1,082,541
|
$108,254
|
Oberholtzer, John
|
CCR (NCI)
|
|
Animal models to study the role of INK4b loss in human acute myeloid leukemia
|
ZIABC011027
|
$687,814
|
$137,563
|
Wolff, Linda
|
CCR (NCI)
|
|
ANTICANCER DRUG DISCOVERY THAT TARGETS TUMOR HYPOXIA
|
5R01CA098787-08
|
$262,130
|
$65,533
|
NAGLE, DALE
|
UNIVERSITY OF MISSISSIPPI
|
|
Anticancer Drug Pharmacology in Very Young Children
|
1R01CA154619-01A1
|
$433,475
|
$433,475
|
STEWART, CLINTON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIASC004020
|
$2,441,667
|
$366,250
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Apoptosis Induced by Glucocorticoids and MEK1/2 Inhibitors in Leukemia
|
5R01CA134473-04
|
$237,412
|
$118,706
|
HARADA, HISASHI
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Assisted Reproductive Technology & Risk of Childhood Cancer
|
5R01CA151973-02
|
$644,373
|
$644,373
|
LUKE, BARBARA
|
MICHIGAN STATE UNIVERSITY
|
|
Basic Mechanisms of Viral and Chemical Carcinogenesis
|
3T32CA009156-38S1
|
$54,231
|
$5,423
|
PAGANO, JOSEPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Basic Mechanisms of Viral and Chemical Carcinogenesis
|
3T32CA009156-38S2
|
$51,963
|
$5,196
|
PAGANO, JOSEPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Basic Mechanisms of Viral and Chemical Carcinogenesis
|
5T32CA009156-38
|
$1,272,412
|
$127,241
|
PAGANO, JOSEPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$82,648
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$4,558
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$8,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$322,823
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
|
5R01CA109821-08
|
$227,207
|
$45,441
|
CHAMBERS, TIMOTHY
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-11S1
|
$140,000
|
$25,200
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-11
|
$771,835
|
$138,930
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Behavioral Science Core
|
ZICBC011288
|
$377,780
|
$377,780
|
Wayne, Alan
|
CCR (NCI)
|
|
BETR Therapy for Herpesvirus-Associated Tumors
|
5R01CA138636-03
|
$550,261
|
$275,131
|
POMPER, MARTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
Bioactive compound modulation of epigenetic regulator Sp1/NFkB/miR network in AML
|
7R21CA155915-02
|
$165,844
|
$165,844
|
Liu, Shujun
|
UNIVERSITY OF MINNESOTA
|
|
Bioinformatic Tools in Cancer Research
|
ZIHBC010470
|
$161,950
|
$8,097
|
Buetow, Kenneth
|
CCR (NCI)
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA
|
ZIABC011002
|
$76,634
|
$76,634
|
Khan, Javed
|
CCR (NCI)
|
|
Biology & Transplantation of the Human Stem Cell
|
3P01CA065493-18S1
|
$65,073
|
$5,206
|
MCGLAVE, PHILIP
|
UNIVERSITY OF MINNESOTA
|
|
Biology & Transplantation of the Human Stem Cell
|
5P01CA065493-18
|
$2,148,642
|
$171,891
|
MCGLAVE, PHILIP
|
UNIVERSITY OF MINNESOTA
|
|
Biology and Prognostic Implications of FLT3 Mutations in AML
|
2R01CA114563-06
|
$463,151
|
$231,576
|
MESHINCHI, SOHEIL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-13
|
$2,006,380
|
$2,006,380
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIABC011334
|
$343,873
|
$343,873
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biostatistics and Data Management Section
|
ZIDSC007202
|
$550,413
|
$55,041
|
Steinberg, Seth
|
CCR (NCI)
|
|
Bone Marrow Micrometastatic Disease in Ewing Sarcoma
|
5K23CA154530-02
|
$163,976
|
$163,976
|
DuBois, Steven
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Ca2+/CaM-Dependent Protein Kinase II: A Novel Target in Osteosarcoma
|
1R43CA159562-01A1
|
$279,182
|
$279,182
|
Schulman, Howard
|
ALLOSTEROS THERAPEUTICS, INC.
|
|
CALGB Member Site: University of California - San Francisco
|
3U10CA138561-03S1
|
$106,497
|
$12,780
|
Ryan, Charles
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIABC011300
|
$619,559
|
$61,956
|
Dean, Michael
|
CCR (NCI)
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
$13,707
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
$931,154
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Childhood Cancers for this search: $208,070,156
|